Lemtrada and Campath Linked with Serious Types of Stroke, FDA Warns - Legal Examiner

Lemtrada and Campath Linked with Serious Types of Stroke, FDA Warns  Legal Examiner

On November 29, 2018, the FDA warned about a rare but serious life-threatening risk of stroke and artery rupture in patients taking the multiple sclerosis (MS) ...